Search

The research focused on sclerosing stromal tumor, a rare, benign ovarian tumor that is not cancer but can be misdiagnosed as cancer.

… Monday, January 27, 2020 Summary Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer. As research has revealed more about the genomics of cancer, it’s changed the way that doctors think about the disease. There is not a single

A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.

… Saturday, October 1, 2011 Summary A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells. In 2008, two research groups in Europe made

In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our mission of ending cancer for life.

… Monday, June 10, 2024 In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our Memorial Sloan Kettering Cancer Center (MSK) mission of ending cancer for life . Every single member of the MSK Giving community was key to this historic success. “We are the most

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.

… Tuesday, September 16, 2014 The Hartford HealthCare Cancer Institute (HHCCI) has been formally certified as the charter member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings

… Wednesday, September 28, 2022 When you ask Jose Casa what he does for a living he says, “I get paid to talk trash.” His answer — delivered with a comedian’s expert timing — clearly oversimplifies the important role Jose has played at Memorial Sloan Kettering Cancer Center (MSK) for almost three decades

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.

… Tuesday, July 26, 2022 Many tumors can be eliminated with surgery , chemotherapy , radiation , and other treatments. But once cancer spreads, or metastasizes, to other parts of the body, it becomes much harder to stop. In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

… Tuesday, October 1, 2013 Summary Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of. VIDEO | 00:14 The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design Video Details This movie clip shows Pseudomonas

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

… Wednesday, December 19, 2012 Summary Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs. Metastasis , the process by which some tumors spread from their site of origin to other body

After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that Lisa M. DeAngelis has been named Physician-in-Chief and Chief Medical Officer. A leading expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.

… Tuesday, September 10, 2019 Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that

During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.

… Friday, May 29, 2020 During the American Society of Clinical Oncology (ASCO) Virtual Scientific Program , Memorial Sloan Kettering (MSK) Medical Oncologist Zsofia K. Stadler, MD , will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted